Update on Epidemiology and Treatment of MRSA Infections in Children

Current Pediatrics Reports

Volumn 1, Issue 3, 2013, Pages 170-181

  David, Michael Z ^a   Daum, Robert S ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

Cystic Fibrosis Patient; Household Contact; Intranasal Mupirocin; Neonatal Intensive Care Unit Patient; SCCmec Type

Indexed keywords

EID: 84907056524     PISSN: None     EISSN: 21674841     Source Type: Journal    
DOI: 10.1007/s40124-013-0023-7     Document Type: Review

References (100)

1. Lowy FD. Staphylococcus aureus infections. N Engl J Med. 1998;339:520–32. DOI: 10.1056/NEJM199808203390806
2. Herold BC, Immergluck LC, Maranan MC, et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA. 1998;279:593–8. DOI: 10.1001/jama.279.8.593
3. Centers for Disease Control and Prevention (CDC). Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus—Minnesota and North Dakota, 1997–1999. MMWR Morb Mortal Wkly Rep. 1999;48:707–10.
4. David MZ, Daum RS. Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev. 2010;23:616–87. DOI: 10.1128/CMR.00081-09
5. Naimi TS, LeDell KH, Como-Sabetti K, et al. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA. 2003;290:2976–84. DOI: 10.1001/jama.290.22.2976
6. Tenover FC, Goering RV. Methicillin-resistant Staphylococcus aureus strain USA300: origin and epidemiology. J Antimicrob Chemother. 2009;64:441–6. DOI: 10.1093/jac/dkp241
7. Chen KT, Huard RC, Della-Latta P, Saiman L. Prevalence of methicillin-sensitive and methicillin-resistant Staphylococcus aureus in pregnant women. Obstet Gynecol. 2006;108:482–7. DOI: 10.1097/01.AOG.0000227964.22439.e3
8. Top KA, Huard RC, Fox Z, et al. Trends in methicillin-resistant Staphylococcus aureus anovaginal colonization in pregnant women in 2005 versus 2009. J Clin Microbiol. 2010;48:3675–80. DOI: 10.1128/JCM.01129-10
9. Ghanim N, Alchyib O, Morrish D, et al. Maternal-neonatal outcome with Staphylococcus aureus rectovaginal colonization. J Reprod Med. 2011;56:421–4.
10. Creech CB, Litzner B, Talbot TR, Schaffner W. Frequency of detection of methicillin-resistant Staphylococcus aureus from rectovaginal swabs in pregnant women. Am J Infect Control. 2010;38:72–4. DOI: 10.1016/j.ajic.2009.06.015
11. Andrews WW, Schelonka R, Waites K. Genital tract methicillin-resistant Staphylococcus aureus: risk of vertical transmission in pregnant women. Obstet Gynecol. 2008;111:113–8. DOI: 10.1097/01.AOG.0000298344.04916.11
12. Reusch M, Ghosh P, Ham C, et al. Prevalence of MRSA colonization in peripartum mothers and their newborn infants. Scand J Infect Dis. 2008;40:667–71. DOI: 10.1080/00365540801946520
13. Lazenby GB, Soper DE, Beardsley W, Salgado CD. Methicillin-resistant Staphylococcus aureus colonization among women admitted for preterm delivery. Am J Obstet Gynecol 2012;206:329.e1–e5.
14. Tomlinson MW, Schmidt NM, Rourke JW Jr. McDonald J: Rectovaginal Staphylococcus aureus colonization: is it a neonatal threat? Am J Perinatol. 2011;28:673–6. DOI: 10.1055/s-0031-1276732
15. Beigi R, Hanrahan J. Staphylococcus aureus and MRSA colonization rates among gravidas admitted to labor and delivery: a pilot study. Infect Dis Obstet Gynecol. 2007;2007:70876. DOI: 10.1155/2007/70876
16. Volk L, Thomson T, Chhangani P, et al. Methicillin-resistant Staphylococcus aureus nasal colonization among women admitted to labor and delivery and their newborn infants. Infect Control Hosp Epidemiol. 2011;32:1045–6. DOI: 10.1086/662018
17. • Jimenez-Truque N, Tedeschi S, Saye EJ, et al. Relationship between maternal and neonatal Staphylococcus aureus colonization. Pediatrics 2012;129:e1252–9. A large study from Memphis, TN, showing that, while infants and mothers may carry concordant MRSA strain types, this is first noted some time after birth, suggesting that peripartum MRSA transmission is not common.
18. Chatzakis E, Scoulica E, Papageorgiou N, et al. Infant colonization by Staphylococcus aureus: role of maternal carriage. Eur J Clin Microbiol Infect Dis. 2011;30:1111–7. DOI: 10.1007/s10096-011-1199-9
19. Gries DM, Zemzars TF, Gibson KA, et al. A pilot study to assess frequency of carriage and routes of acquisition of Staphylococcus aureus by healthy infants. Am J Infect Control. 2009;37:598–600. DOI: 10.1016/j.ajic.2008.12.003
20. • Carey AJ, Della-Latta P, Huard R, et al. Changes in the molecular epidemiological characteristics of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. Infect Control Hosp Epidemiol 2010;31:613–9. An early report of the strain shift in a large NICU on the East Coast of the United States over a 9-year period from HA-MRSA (USA100) to USA300, the predominant CA-MRSA strain type in the U.S., based on culture results of more than 1,300 infants.
21. Hermos CR, Sandora TJ, Williams LE, et al. Changing epidemiology of methicillin-resistant Staphylococcus aureus colonization in paediatric intensive-care units. Epidemiol Infect. 2012;29:1–10.
22. Rana D, Abughali N, Kumar D, et al. Staphylococcus aureus, including community-acquired methicillin-resistant S. aureus, in a level III NICU: 2001 to 2008. Am J Perinatol. 2012;29:401–8. DOI: 10.1055/s-0032-1304819
23. Shane AL, Stoll BJ. Recent developments and current issues in the epidemiology, diagnosis, and management of bacterial and fungal neonatal sepsis. Am J Perinatol. 2013;30:131–41. DOI: 10.1055/s-0032-1333413
24. Gregory ML, Eichenwald EC, Puopolo KM. Seven-year experience with a surveillance program to reduce methicillin-resistant Staphylococcus aureus colonization in a neonatal intensive care unit. Pediatrics. 2009;123:e790–6. DOI: 10.1542/peds.2008-1526
25. Myers PJ, Marcinak J, David MZ, et al. Universal admission screening for methicillin-resistant Staphylococcus aureus in a level IIID neonatal intensive care unit: the first 9 months. Infect Control Hosp Epidemiol. 2011;32:398–400. DOI: 10.1086/659153
26. • Milstone AM, Carroll KC, Ross T, et al. Community-associated methicillin-resistant Staphylococcus aureus strains in pediatric intensive care unit. Emerg Infect Dis 2010;16:647–55. An unusual study of MRSA in a PICU including genotyping of collected strains in 2007–2008 demonstrating the predominance of CA-MRSA.
27. Farr AM, Aden B, Weiss D, et al. Trends in hospitalization for community-associated methicillin-resistant Staphylococcus aureus in New York City, 1997–2006: data from New York State’s Statewide Planning and Research Cooperative System. Infect Control Hosp Epidemiol. 2012;33:725–31. DOI: 10.1086/666329
28. Hudson LO, Murphy CR, Spratt BG, et al. Differences in methicillin-resistant Staphylococcus aureus strains isolated from pediatric and adult patients from hospitals in a large county in California. J Clin Microbiol. 2012;50:573–9. DOI: 10.1128/JCM.05336-11
29. Dukic VM, Lauderdale DS, Wilder J, et al. Epidemics of community-associated methicillin-resistant Staphylococcus aureus in the United States: a meta-analysis. PLoS ONE. 2013;8(1):e52722. DOI: 10.1371/journal.pone.0052722
30. Frei CR, Makos BR, Daniels KR, Oramasionwu CU. Emergence of community-acquired methicillin-resistant Staphylococcus aureus skin and soft tissue infections as a common cause of hospitalization in United States children. J Pediatr Surg. 2010;45:1967–74. DOI: 10.1016/j.jpedsurg.2010.05.009
31. Lautz TB, Raval MV, Barsness KA. Increasing national burden of hospitalizations for skin and soft tissue infections in children. J Pediatr Surg. 2011;46:1935–41. DOI: 10.1016/j.jpedsurg.2011.05.008
32. Herigon JC, Hersh AL, Gerber JS, et al. Antibiotic management of Staphylococcus aureus infections in US children’s hospitals, 1999–2008. Pediatrics. 2010;125:e1294–300. DOI: 10.1542/peds.2009-2867
33. Matlow A, Forgie S, Pelude L, et al. National surveillance of methicillin-resistant Staphylococcus aureus among hospitalized pediatric patients in Canadian acute care facilities, 1995–2007. Pediatr Infect Dis J. 2012;31:814–20. DOI: 10.1097/INF.0b013e31825c48a0
34. •• Gutierrez K, Halpern MS, Sarnquist C, et al. Staphylococcal infections in children, California, USA, 1985–2009. Emerg Infect Dis 2013;19:10–20. Among the largest and most thorough population-based studies of S. aureus infections in hospitalized children ever reported, this 25-year review of MSSA and MRSA infections demonstrated that there was a massive increase in the S. aureus-associated hospitalization rate in California children from the 1980s to 2006. This rise was fueled by the CA-MRSA epidemic, which disproportionately affected children <3 years of age and black children, as demonstrated by a state hospital discharge database.
35. Humphries RM, Deville JG. The Changing Epidemiology of Methicillin-Resistant Staphylococcus aureus in Pediatric Wound Cultures: 10-Year Experience. Clin Pediatr (Phila). 2012;52(6):570–3. DOI: 10.1177/0009922812436551
36. Miller MB, Weber DJ, Goodrich JS, et al. Prevalence and risk factor analysis for methicillin-resistant Staphylococcus aureus nasal colonization in children attending child care centers. J Clin Microbiol. 2011;49:1041–7. DOI: 10.1128/JCM.02235-10
37. Hewlett AL, Falk PS, Hughes KS, Mayhall CG. Epidemiology of methicillin-resistant Staphylococcus aureus in a university medical center day care facility. Infect Control Hosp Epidemiol. 2009;30:985–92. DOI: 10.1086/605721
38. Lee J, Sung JY, Kim YM, et al. Molecular characterization of methicillin-resistant Staphylococcus aureus obtained from the anterior nares of healthy Korean children attending daycare centers. Int J Infect Dis. 2011;15:e558–63. DOI: 10.1016/j.ijid.2011.04.010
39. Ho PL, Chiu SS, Chan MY, et al. Molecular epidemiology and nasal carriage of Staphylococcus aureus and methicillin-resistant S. aureus among young children attending day care centers and kindergartens in Hong Kong. J Infect. 2012;64:500–6. DOI: 10.1016/j.jinf.2012.02.018
40. Blumental S, Deplano A, Jourdain S, et al. Dynamic pattern and genotypic diversity of Staphylococcus aureus nasopharyngeal carriage in healthy pre-school children. J Antimicrob Chemother. 2013;. doi:10.1093/jac/dkt080.
41. Tavares DA, Sá-Leão R, Miragaia M, de Lencastre H. Large screening of CA-MRSA among Staphylococcus aureus colonizing healthy young children living in two areas (urban and rural) of Portugal. BMC Infect Dis. 2010;10:110. DOI: 10.1186/1471-2334-10-110
42. Gardella N, Murzicato S, Di Gregorio S, et al. Prevalence and characterization of methicillin-resistant Staphylococcus aureus among healthy children in a city of Argentina. Infect Genet Evol. 2011;11:1066–71. DOI: 10.1016/j.meegid.2011.03.019
43. Rebollo-Pérez J, Ordoñez-Tapia C, Herazo–Herazo C, Reyes-Ramos N. Nasal carriage of Panton Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus in healthy preschool children. Rev Salud Publica (Bogota). 2011;13:824–32. DOI: 10.1590/S0124-00642011000500011
44. Nickerson EK, Wuthiekanun V, Kumar V, et al. Emergence of community-associated methicillin-resistant Staphylococcus aureus carriage in children in Cambodia. Am J Trop Med Hyg. 2011;84:313–7. DOI: 10.4269/ajtmh.2011.10-0300
45. Sedighi I, Moez HJ, Alikhani MY. Nasal carriage of methicillin resistant Staphylococcus aureus and their antibiotic susceptibility patterns in children attending day-care centers. Acta Microbiol Immunol Hung. 2011;58:227–34. DOI: 10.1556/AMicr.58.2011.3.6
46. Adler A, Givon-Lavi N, Moses AE, et al. Carriage of community-associated methicillin-resistant Staphylococcus aureus in a cohort of infants in southern Israel: risk factors and molecular features. J Clin Microbiol. 2010;48:531–8. DOI: 10.1128/JCM.02290-08
47. Chen CJ, Hsu KH, Lin TY, et al. Factors associated with nasal colonization of methicillin-resistant Staphylococcus aureus among healthy children in Taiwan. J Clin Microbiol. 2011;49:131–7. DOI: 10.1128/JCM.01774-10
48. Lo WT, Wang CC, Lin WJ, et al. Changes in the nasal colonization with methicillin-resistant Staphylococcus aureus in children: 2004–2009. PLoS ONE. 2010;5(12):e15791. DOI: 10.1371/journal.pone.0015791
49. Creech CB 2nd, Kernodle DS, Alsentzer A, et al. Increasing rates of nasal carriage of methicillin-resistant Staphylococcus aureus in healthy children. Pediatr Infect Dis J. 2005;24:617–21. DOI: 10.1097/01.inf.0000168746.62226.a4
50. Nerby JM, Gorwitz R, Lesher L, et al. Risk factors for household transmission of community-associated methicillin-resistant Staphylococcus aureus. Pediatr Infect Dis J. 2011;30:927–32. DOI: 10.1097/INF.0b013e31822256c3
51. Rafee Y, Abdel-Haq N, Asmar B, et al. Increased prevalence of methicillin-resistant Staphylococcus aureus nasal colonization in household contacts of children with community acquired disease. BMC Infect Dis. 2012;12:45. DOI: 10.1186/1471-2334-12-45
52. Miller LG, Eells SJ, Taylor AR, et al. Staphylococcus aureus colonization among household contacts of patients with skin infections: risk factors, strain discordance, and complex ecology. Clin Infect Dis. 2012;54:1523–35. DOI: 10.1093/cid/cis213
53. • Mongkolrattanothai K, Gray BM, Mankin P, et al. Simultaneous carriage of multiple genotypes of Staphylococcus aureus in children. J Med Microbiol 2011;60:317–2. Adds to the literature on polyclonal S. aureus carriage, showing that more than one-quarter of 125 tested children prior to surgery in Illinois carried 2 or more distinct strain types.
54. Early GJ, Seifried SE. Risk factors for community-associated Staphylococcus aureus skin infection in children of Maui. Hawaii J Med Public Health. 2012;71(8):218–23.
55. • Fritz SA, Epplin EK, Garbutt J, Storch GA. Skin infection in children colonized with community-associated methicillin-resistant Staphylococcus aureus. J Infect 2009;59:394–401. Although it relies on self-reported skin lesions, this is an excellent study on SSTIs in children in 2006-7 in a Midwestern U.S. city. Identified household contact with an SSTI patient in the previous 6 months and a history of SSTI in the patient him- or herself within a year, but not MRSA nasal carriage, as independent risk factors for SSTI.
56. Schneider-Lindner V, Quach C, Hanley JA, Suissa S. Antibacterial drugs and the risk of community-associated methicillin-resistant Staphylococcus aureus in children. Arch Pediatr Adolesc Med. 2011;165:1107–14. DOI: 10.1001/archpediatrics.2011.143
57. Milstone AM, Goldner BW, Ross T, et al. Methicillin-resistant Staphylococcus aureus colonization and risk of subsequent infection in critically ill children: importance of preventing nosocomial methicillin-resistant Staphylococcus aureus transmission. Clin Infect Dis. 2011;53:853–9. DOI: 10.1093/cid/cir547
58. Advani S, Sengupta A, Milstone AM. Postdischarge surveillance to identify subsequent methicillin-resistant Staphylococcus aureus infections in colonized children. Am J Infect Control. 2013;. doi:10.1016/j.ajic.2012.12.016.
59. Cystic Fibrosis Foundation Patient Registry 2011 Annual Data Report. Bethesda, MD, Cystic Fibrosis Foundation; 2012.
60. Elizur A, Orscheln RC, Ferkol TW, et al. Panton–Valentine Leukocidin-positive methicillin-resistant Staphylococcus aureus lung infection in patients with cystic fibrosis. Chest. 2007;131:1718–25. DOI: 10.1378/chest.06-2756
61. Glikman D, Siegel JD, David MZ, et al. Complex molecular epidemiology of methicillin-resistant Staphylococcus aureus isolates from children with cystic fibrosis in the era of epidemic community-associated methicillin-resistant S. aureus. Chest. 2008;133:1381–7. DOI: 10.1378/chest.07-2437
62. Ren CL, Morgan WJ, Konstan MW, et al. Presence of methicillin resistant Staphylococcus aureus in respiratory cultures from cystic fibrosis patients is associated with lower lung function. Pediatr Pulmonol. 2007;42:513–8. DOI: 10.1002/ppul.20604
63. Sanders DB, Bittner RC, Rosenfeld M, et al. Failure to recover to baseline pulmonary function after cystic fibrosis pulmonary exacerbation. Am J Respir Crit Care Med. 2010;182:627–32. DOI: 10.1164/rccm.200909-1421OC
64. •• Dasenbrook EC, Checkley W, Merlo CA, et al. Association between respiratory tract methicillin-resistant Staphylococcus aureus and survival in cystic fibrosis. JAMA. 2010;303:2386–92. A study of nearly 20,000 pediatric and adult CF patients demonstrating an association of increased hazard of death with persistent MRSA carriage in the respiratory tract.
65. Muhlebach MS, Miller M, LaVange LM, et al. Treatment intensity and characteristics of MRSA infection in CF. J Cyst Fibros. 2011;10:201–6. DOI: 10.1016/j.jcf.2011.02.004
66. Sawicki GS, Rasouliyan L, Ren CL. The impact of MRSA on lung function in patients with cystic fibrosis. Am J Respir Crit Care Med. 2009;179:734–5. DOI: 10.1164/ajrccm.179.8.734a
67. • Abdel-Haq N, Quezada M, Asmar BI. Retropharyngeal abscess in children: the rising incidence of methicillin-resistant Staphylococcus aureus. Pediatr Infect Dis J 2012;31:696–9. A 10-year study of pediatric retropharyngeal abscesses in a single medical center showing a marked rise in the percent of lesions caused by S. aureus and caused by MRSA between 1993 and 2003. This is a clear demonstration of a shift in the etiology of a relatively common, life-threatening childhood infection in the CA-MRSA era.
68. Duggal P, Naseri I, Sobol SE. The increased risk of community-acquired methicillin-resistant Staphylococcus aureus neck abscesses in young children. Laryngoscope. 2011;121:51–5. DOI: 10.1002/lary.21214
69. Walker PC, Karnell LH, Ziebold C, Kacmarynski DS. Changing microbiology of pediatric neck abscesses in Iowa 2000–2010. Laryngoscope. 2013;123:249–52. DOI: 10.1002/lary.23500
70. Alexander AJ, Richardson SE, Sharma A, Campisi P. The increasing prevalence of clindamycin resistance in Staphylococcus aureus isolates in children with head and neck abscesses. Can J Infect Dis Med Microbiol. 2011;22:49–51.
71. Obando I, Valderrabanos ES, Millan JA, Neth OW. Necrotising pneumonia due to influenza A (H1N1) and community-acquired methicillin-resistant Staphylococcus aureus clone USA300: successful management of the first documented paediatric case. Arch Dis Child. 2010;95:305–6.
72. Kimata T, Tsuji S, Yoshimura K, et al. Methicillin-resistant Staphylococcus aureus-related glomerulonephritis in a child. Pediatr Nephrol. 2012;27:2149–52. DOI: 10.1007/s00467-012-2229-2
73. Randolph AG, Vaughn F, Sullivan R, et al. Critically ill children during the 2009–2010 influenza pandemic in the United States. Pediatrics. 2011;128:e1450–8. DOI: 10.1542/peds.2011-0774
74. Lalich IJ, Sam-Agudu NA. Community-acquired methicillin-resistant Staphylococcus aureus necrotizing fasciitis in a healthy adolescent male. Minn Med. 2010;93:44–6.
75. Fitzgerald CJ, Pranikoff TV, Ross GA, et al. Purpura fulminans caused by community-associated methicillin-resistant Staphylococcus aureus. Am J Emerg Med 2012;30:1013.e1–4.
76. Walls T, Williams G, Adams S, et al. Neonatal necrotizing fasciitis following superficial skin infection with community-associated methicillin-resistant Staphylococcus aureus. J Paediatr Child Health. 2011;47:918–20. DOI: 10.1111/j.1440-1754.2010.01732.x
77. Gouveia C, Gavino A, Bouchami O, et al. Community-associated methicillin-resistant Staphylococcus aureus lacking PVL, as a cause of severe invasive infection treated with linezolid. Case Rep Pediatr. 2013;2013:727824.
78. Carvalho Ferreira D, Cisne Frota AC, Cavalcante FS, et al. Necrotizing fasciitis secondary to community pneumonia by Panton–Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus. Am J Respir Crit Care Med. 2012;186:202–3. DOI: 10.1164/ajrccm.186.2.202
79. Verma P, Pandhi D, Yadav P, Dhawan AK. Neonatal purpura fulminans due to methicillin resistant Staphylococcus aureus. Pediatr Dermatol. 2013;30:266–7. DOI: 10.1111/j.1525-1470.2011.01674.x
80. Schaub RL, Rodkey ML. Deep vein thrombosis and septic pulmonary emboli with MRSA osteomyelitis in a pediatric patient. Pediatr Emerg Care. 2012;28:911–2. DOI: 10.1097/PEC.0b013e318267ea4e
81. Carrillo-Marquez MA, Hulten KG, Hammerman W, et al. USA300 is the predominant genotype causing Staphylococcus aureus septic arthritis in children. Pediatr Infect Dis J. 2009;28:1076–80. DOI: 10.1097/INF.0b013e3181adbcfe
82. Bukhari EE, Al-Otaibi FE. Severe community-acquired infection caused by methicillin-resistant Staphylococcus aureus in Saudi Arabian children. Saudi Med J. 2009;30:1595–600.
83. Chung WC, Lin HJ, Foo NP, Chen KT. Infantile orbital abscess caused by community-acquired methicillin-resistant Staphylococcus aureus. J Ophthalmic Inflamm Infect. 2011;1:181–3. DOI: 10.1007/s12348-011-0030-1
84. Lei TH, Huang YC, Chu YC, et al. Orbital cellulitis caused by community-associated methicillin-resistant Staphylococcus aureus in a previously healthy neonate. J Microbiol Immunol Infect. 2013;46:136–8. DOI: 10.1016/j.jmii.2012.01.015
85. Vaska VL, Grimwood K, Gole GA, et al. Community-associated methicillin-resistant Staphylococcus aureus causing orbital cellulitis in Australian children. Pediatr Infect Dis J. 2011;30:1003–6. DOI: 10.1097/INF.0b013e318224fda5
86. Kobayashi D, Givner LB, Yeatts RP, et al. Infantile orbital cellulitis secondary to community-associated methicillin-resistant Staphylococcus aureus. J AAPOS. 2011;15:208–10. DOI: 10.1016/j.jaapos.2011.01.153
87. Carrillo-Marquez MA, Hulten KG, Mason EO, Kaplan SL. Clinical and molecular epidemiology of Staphylococcus aureus catheter-related bacteremia in children. Pediatr Infect Dis J. 2010;29:410–4. DOI: 10.1097/INF.0b013e3181c767b6
88. Gaur L, Madan S, Morell V, Arora G. Formation of ventricular aneurysm after endocarditis in a child with methicillin-resistant Staphylococcus aureus (MRSA) bacteremia. Pediatr Cardiol. 2011;32:1062–4. DOI: 10.1007/s00246-011-0044-3
89. Bowen DK, Mitchell LA, Burnett MW, et al. Spinal epidural abscess due to tropical pyomyositis in immunocompetent adolescents. J Neurosurg Pediatr. 2010;6:33–7. DOI: 10.3171/2010.3.PEDS1017
90. Hoehn KS, Capouya JD, Daum RS, et al. Lemierre-like syndrome caused by community-associated methicillin-resistant Staphylococcus aureus complicated by hemorrhagic pericarditis. Pediatr Crit Care Med. 2010;11:e32–5. DOI: 10.1097/PCC.0b013e3181b806cb
91. Groome MJ, Albrich WC, Wadula J, et al. Community-onset Staphylococcus aureus bacteraemia in hospitalised African children: high incidence in HIV-infected children and high prevalence of multidrug resistance. Paediatr Int Child Health. 2012;32:140–6. DOI: 10.1179/1465328111Y.0000000044
92. Holsenback H, Smith L, Stevenson MD. Cutaneous abscesses in children: epidemiology in the era of methicillin-resistant Staphylococcus aureus in a pediatric emergency department. Pediatr Emerg Care. 2012;28:684–6. DOI: 10.1097/PEC.0b013e31825d20e1
93. • Fritz SA, Hogan PG, Hayek G, et al. Household versus individual approaches to eradication of community-associated Staphylococcus aureus in children: a randomized trial. Clin Infect Dis 2012;54:743–51. A trial of children after therapy for a S. aureus skin infection to assess the efficacy of individual decolonization compared with decolonization of the index patient plus all household contacts with chlorhexidine baths plus intransal mupirocin ointment; demonstrated that there is little difference in colonization prevalence, but recurrent skin infections may be less common in the subsequent year if all household contacts undergo decolonization.
94. Chen CJ, Su LH, Lin TY, Huang YC. Molecular analysis of repeated methicillin-resistant Staphylococcus aureus infections in children. PLoS ONE. 2010;5(12):e14431. DOI: 10.1371/journal.pone.0014431
95. •• Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 2011;52:e18–e55. Erratum in: Clin Infect Dis 2011;53:319. Provides a comprehensive review of the literature on therapy for invasive and non-invasive MRSA infections as well as concrete guidelines for therapy.
96. Chen AE, Carroll KC, Diener-West M, et al. Randomized controlled trial of cephalexin versus clindamycin for uncomplicated pediatric skin infections. Pediatrics. 2011;127:e573–80. DOI: 10.1542/peds.2010-2053
97. Duong M, Markwell S, Peter J, Barenkamp S. Randomized, controlled trial of antibiotics in the management of community-acquired skin abscesses in the pediatric patient. Ann Emerg Med. 2010;55:401–7. DOI: 10.1016/j.annemergmed.2009.03.014
98. Williams DJ, Cooper WO, Kaltenbach LA, et al. Comparative effectiveness of antibiotic treatment strategies for pediatric skin and soft-tissue infections. Pediatrics. 2011;128:e479–87.
99. •• Fritz SA, Camins BC, Eisenstein KA, et al. Effectiveness of measures to eradicate Staphylococcus aureus carriage in patients with community-associated skin and soft-tissue infections: a randomized trial. Infect Control Hosp Epidemiol 2011;32:872–80. A well-designed, randomized, controlled trial of different regimens to decrease S. aureus carriage prevalence in adults and children in the community.
100. Daum RS, Spellberg B. Progress toward a Staphylococcus aureus vaccine. Clin Infect Dis. 2012;54:560–7. DOI: 10.1093/cid/cir828